The pharma industry’s to-do list for 2014 includes creating pedigrees for tracking shipments of drug lots – a federal requirement that firms actually welcomed since it overrode what would have been more onerous mandates from California.
But even though industry now has more time to ramp up to an eventual unit-level track-and-trace system, getting there isn’t necessarily going to be easy, as firms that have made...